Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | ES1 - Emerging Science

Tuesday 04/05/22
11:30 AM - 12:45 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
General Neurology
1.25 CME credits

Program Materials Program Evaluations

Event Timeline
11:30 AM - 11:30 AM PDT Speaker Walk-in Slides
Erin Jackson
11:30 AM - 11:36 AM PDT Abstract 001 - The pivotal multi-center, randomized, double-blind, placebo-controlled trial of Intra-Erythrocyte Dexamethasone Sodium Phosphate (ATTeST) on the neurological motor function of people with Ataxia Telangiectasia
Stefan Zielen, MD
11:36 AM - 11:42 AM PDT Abstract 002 - Ecopipam in Children and Adolescents with Tourette Syndrome: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2b Study
Atul Mahableshwarkar
11:42 AM - 11:48 AM PDT Abstract 003 - KINECT HD: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Valbenazine for Chorea Associated with Huntington Disease (HD)
Erin Furr-Stimming, MD, FAAN
11:48 AM - 11:54 AM PDT Abstract 004 - Plasma-Based Biomarkers in Phase 2 Study of Donanemab in Early, Symptomatic Alzheimer’s Disease
Michael J. Pontecorvo, PhD
11:54 AM - 12:00 PM PDT Abstract 005 - Long-Term Safety of a Fully Implanted Endovascular Brain-Computer Interface for Severe Paralysis: Results of SWITCH, a First-in-Human Study
Bruce Campbell, MD, FAAN, Peter John Mitchell, MBBS
12:00 PM - 12:06 PM PDT Abstract 006 - SAGE-718 in Patients With Mild Cognitive Impairment or Mild Dementia due to Alzheimer's Disease: Results From the Phase 2 LUMINARY Study
Aaron Koenig
12:06 PM - 12:12 PM PDT Abstract 007 - Long-Term Survival of Randomized Participants Enrolled in the Phase 2 RESCUE-ALS Trial of CNM-Au8, A Cellular Energetic Catalyst
Matthew Colm Kiernan, PhD, FRACP, MBBS
12:12 PM - 12:18 PM PDT Abstract 008 - Comparative Safety and Efficacy of Different Corticosteroid Regimens for Duchenne Muscular Dystrophy: Results of an International Randomized Controlled Trial
Michela Guglieri
12:18 PM - 12:24 PM PDT Abstract 009 - Lecanemab: An Assessment of the Clinical Effects, the Correlation of Plasma Aβ 42/40 Ratio With Changes in Brain Amyloid PET SUVr, and Safety from the Core and Open Label Extension of the Phase 2 Proof-of-Concept Study, BAN2401-G000-201, in Subjects With Early Alzheimer’s Disease (AD)
Chad J Swanson
12:24 PM - 12:30 PM PDT Abstract 010 - Effectiveness of COVID-19 Vaccines in Multiple Sclerosis Patients Receiving Disease-Modifying Therapies in England
Afagh Garjani, MD
12:30 PM - 12:36 PM PDT Abstract 011 - Efficacy and safety of P2B001 in the management of early Parkinson’s disease. Results from a phase 3, randomized, double-blind, double-dummy controlled trial
C. Warren Olanow, MD
Faculty Disclosures
Nicholas Elwood Johnson, MD, FAAN Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapuetics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Johnson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ML BIo . Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Johnson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Arthex. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Juvena. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Entrada. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rgenta. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angle Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Johnson has stock in Angle Therapeutics. Dr. Johnson has stock in Juvena Therapeutics. The institution of Dr. Johnson has received research support from Novartis. The institution of Dr. Johnson has received research support from Takeda . The institution of Dr. Johnson has received research support from AMO Pharma. The institution of Dr. Johnson has received research support from Sarepta. The institution of Dr. Johnson has received research support from Dyne Therapeutics. The institution of Dr. Johnson has received research support from AskBio. The institution of Dr. Johnson has received research support from Pepgen. The institution of Dr. Johnson has received research support from ML Bio. The institution of Dr. Johnson has received research support from Vertex. The institution of Dr. Johnson has received research support from Arthex. Dr. Johnson has received intellectual property interests from a discovery or technology relating to health care.
Fernando D. Testai, MD, PhD, FAAN Dr. Testai has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Testai has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Swanson Martin & Bell, LLP. Dr. Testai has received publishing royalties from a publication relating to health care.
Mauro Magnani, PhD Prof. Magnani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EryDel SpA. Prof. Magnani has stock in EryDel SpA.
Stefan Zielen, MD Prof. Zielen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Erydel. Prof. Zielen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Engelhard. Prof. Zielen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi/Pasteuer.
Vincenzo Leuzzi Vincenzo Leuzzi has nothing to disclose.
Howard M. Lederman, MD, PhD Dr. Lederman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EryDel. The institution of Dr. Lederman has received research support from EryDel.
Susan L. Perlman, MD Dr. Perlman has nothing to disclose.
William Whitehouse No disclosure on file
David J. Kim, Other Mr. Kim has received personal compensation for serving as an employee of Emalex Biosciences.
Donald Gilbert, MD, FAAN Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex Biosciences. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. The institution of Dr. Gilbert has received research support from NIMH. The institution of Dr. Gilbert has received research support from Emalex. The institution of Dr. Gilbert has received research support from PTC Therapeutics. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Second Opinion Expert with Teldoc/Advanced Medical. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Expert with Department of Health and Human Services/Vaccine Injury Compensation Program.
Sarah * Use 386720Diana Atkinson, MD Dr. Atkinson has received personal compensation for serving as an employee of Evolution Research Group. The institution of Dr. Atkinson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant .
Stephen Wanaski, PhD Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has stock in Paragon Biosciences. Dr. Wanaski has stock in Emalex Biosciences.
Meredith M. Miller Mrs. Miller has received personal compensation for serving as an employee of Emalex Biosciences. Mrs. Miller has stock in Emalex Biosciences.
Timothy Cunniff, PharmD Dr. Cunniff has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Cunniff has stock in Harmony Biosciences. Dr. Cunniff has stock in Emalex Biosciences.
Jordan Scott Dubow, MD Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Avadel Pharmaceuticals.
Atul Mahableshwarkar Atul Mahableshwarkar has received personal compensation for serving as an employee of Emalex Biosciences. Atul Mahableshwarkar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ecor1 Capital. Atul Mahableshwarkar has stock in Johnson & Johnson.
C. Warren Olanow, MD Dr. Olanow has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Chevron/Syngenta. Dr. Olanow has stock in Clintrex Research Corporation.
Pninit Litman, PhD Dr. Litman has received personal compensation for serving as an employee of PHARMA 2B.
Karl D. Kieburtz, MD, FAAN Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation.
Hadas Friedman, Other Mrs. Friedman has received personal compensation for serving as an employee of Pharma Two B.
Sheila Oren, MD, MBA Sheila Oren, MD, MBA has received personal compensation for serving as an employee of Neuroderm. Sheila Oren, MD, MBA has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuroderm.
Mark A. Mintun, MD Dr. Mintun has received personal compensation for serving as an employee of Eli Lilly & Co.
Ming Lu Ming Lu has received personal compensation for serving as an employee of Eli Lilly and Company. Ming Lu has received stock or an ownership interest from Eli Lilly and Company.
Dawn A. Brooks, PhD An immediate family member of Dr. Brooks has received personal compensation for serving as an employee of Indiana Hospital Association. Dr. Brooks has received stock or an ownership interest from Eli Lilly and Company.
Andrew Schade, MD,PhD Dr. Schade has received personal compensation for serving as an employee of Eli Lilly & Co. Dr. Schade has stock in Eli Lilly & Co.
Emily Catherine Collins, PhD Dr. Collins has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Collins has stock in Eli Lilly and Company.
Sergey Shcherbinin Dr. Shcherbinin has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Shcherbinin has stock in Eli Lilly and Company.
Samantha Burnham, PhD Dr. Burnham has received personal compensation for serving as an employee of AvidRadiopharmaceuticals. Dr. Burnham has received intellectual property interests from a discovery or technology relating to health care.
John R. Sims, MD Dr. Sims has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Sims has stock in Eli Lilly and Company.
Michael J. Pontecorvo, PhD Dr. Pontecorvo has received personal compensation for serving as an employee of Eli Lilly. Dr. Pontecorvo has stock in Eli Lilly.
Jeffrey Dage, PhD Dr. Dage has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Dage has stock in Eli Lilly and Company. Dr. Dage has stock in General Electric. Dr. Dage has received research support from Indiana University School Of Medicine. Dr. Dage has received intellectual property interests from a discovery or technology relating to health care.
Bruce Campbell, MD, FAAN Dr. Campbell has nothing to disclose.
Douglas Weber, PhD Prof. Weber has received personal compensation for serving as an employee of Carnegie Mellon University. Prof. Weber has received personal compensation for serving as an employee of Iota Biosciences. Prof. Weber has stock in Microsoft. Prof. Weber has stock in Meta Platforms. Prof. Weber has stock in Apple. The institution of Prof. Weber has received research support from NIH. The institution of Prof. Weber has received research support from DARPA. The institution of Prof. Weber has received research support from Lockheed Martin. Prof. Weber has received intellectual property interests from a discovery or technology relating to health care.
J Mocco No disclosure on file
Kate Drummond, Jr. Prof. Drummond has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Prof. Drummond has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for KL Gates. Prof. Drummond has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Australian Defence Force. The institution of Prof. Drummond has received research support from NHMRC. The institution of Prof. Drummond has received research support from MRFF.
Andrew Morokoff No disclosure on file
Steven John Bush, MD Dr. Bush has nothing to disclose.
Edward Karst Edward Karst has received personal compensation for serving as an employee of Synchron. Edward Karst has received personal compensation for serving as an employee of Abbott.
Christopher MacIsaac Prof. MacIsaac has nothing to disclose.
Peter E. Yoo, PhD No disclosure on file
Lia Madariaga No disclosure on file
Zafar Faraz No disclosure on file
Timothy Denison No disclosure on file
Anna Helene Balabanski, MBBS Dr. Balabanski has received research support from National Health and Medical Research (NHMRC) of Australia. Dr. Balabanski has received personal compensation in the range of $0-$499 for serving as a Guest Speaker with The Australian Stroke Academy.
Susan Mathers The institution of Susan Mathers has received research support from Victorian Government, Department of Health and Human Services. The institution of Susan Mathers has received research support from Motor Neurone Disease Research Australia.
Patricia Desmond The institution of Patricia Desmond has received research support from NHMRC.
Gil Rind Mr. Rind has received personal compensation for serving as an employee of Synchron. Mr. Rind has received research support from NHMRC. Mr. Rind has received intellectual property interests from a discovery or technology relating to health care.
Ivan Vrljic No disclosure on file
Natalie Dawn DeWitt, PhD Dr. DeWitt has received personal compensation for serving as an employee of Synchron, Inc.. Dr. DeWitt has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Devicia AB. Dr. DeWitt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for JA Reynolds and Associates. Dr. DeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kodikaz Therapeutic Solutions. Dr. DeWitt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Synchron Inc.. Dr. DeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Incando. Dr. DeWitt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with AAAS.
James David Bennett, PhD Dr. Bennett has received personal compensation for serving as an employee of Synchron.
Rahul Sharma No disclosure on file
Chiu Mun Sarah Lee, MD Dr. Lee has nothing to disclose.
David Grayden, PhD Prof. Grayden has a non-compensated relationship as a Research Collaborator with Synchron Corp that is relevant to AAN interests or activities.
Nicholas Opie, PhD Prof. Opie has received personal compensation for serving as an employee of Synchorn. Prof. Opie has stock in Synchron. The institution of Prof. Opie has received research support from NHMRC.
Terence John O'Brien, MD The institution of Prof. O'Brien has received research support from Eisai. The institution of Prof. O'Brien has received research support from UCB. The institution of Prof. O'Brien has received research support from BioGen. The institution of Prof. O'Brien has received research support from ES Theraputics. The institution of an immediate family member of Prof. O'Brien has received research support from Epidarex.
Thomas Oxley, MD No disclosure on file
Peter Mitchell No disclosure on file
Aaron Koenig Aaron Koenig has received personal compensation for serving as an employee of Sage Therapeutics.
Jennifer Petrillo Billet, PhD Jennifer Petrillo, 14951 has received personal compensation for serving as an employee of Sage Therapeutics. Jennifer Petrillo, 14951 has received stock or an ownership interest from Sage Therapeutics.
Jeffrey Wald Jeffrey Wald has received personal compensation for serving as an employee of Sage Therapeutics. Jeffrey Wald has received stock or an ownership interest from Sage Thereapeutics.
Sigui Li Sigui Li has received personal compensation for serving as an employee of SAGE Therapeutics.
Shishuka Malhotra, MD Dr. Malhotra has nothing to disclose.
Katrina Paumier, PhD Dr. Paumier has nothing to disclose.
James Doherty, PhD Dr. Doherty has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Doherty has received stock or an ownership interest from Sage Therapeutics.
Michael Quirk Michael Quirk has received personal compensation for serving as an employee of Sage Therapeutics. Michael Quirk has received stock or an ownership interest from Sage Therapeutics.
Jason K. Johannesen, PhD,MD Dr. Johannesen has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Johannesen has stock in Sage Therapeutics . Dr. Johannesen has received research support from National Institute of Health. Dr. Johannesen has received research support from Brain & Behavior Research Foundation . Dr. Johannesen has received research support from VA office of Rehabilitation Research & Development.
Emily Freitag, Other Ms. Freitag has nothing to disclose.
Matthew Colm Kiernan, PhD, FRACP, MBBS The institution of Prof. Kiernan has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for British Medical Journal Publishers (UK).
Parvathi Menon The institution of Parvathi Menon, 5121 has received research support from MNDRA.
Ostoja (Steve) Vucic, FRACP, MBBS Prof. Vucic has a non-compensated relationship as a Member-Advisory Board with Biogen Idec Australia that is relevant to AAN interests or activities. Prof. Vucic has a non-compensated relationship as a Honorarium with Merkc Serono Ausralia that is relevant to AAN interests or activities.
Austin Rynders, RN Mr. Rynders has received personal compensation for serving as an employee of Clene Nanomedicine. An immediate family member of Mr. Rynders has received personal compensation for serving as an employee of Recursion Pharmaceuticals. Mr. Rynders has stock in Clene Nanomedicine. An immediate family member of Mr. Rynders has stock in Recursion Pharmaceuticals.
Michael Hotchkin Mr. Hotchkin has received personal compensation for serving as an employee of Clene Nanomedicine, Inc. Mr. Hotchkin has stock in Clene Nanomedicine, Inc.
Michela Guglieri The institution of Michela Guglieri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. The institution of Michela Guglieri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne. The institution of Michela Guglieri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NS Pharma. Michela Guglieri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. The institution of Michela Guglieri has received research support from EC - H2020. The institution of Michela Guglieri has received research support from Duchenne UK. The institution of Michela Guglieri has received research support from Sarepta. The institution of Michela Guglieri has received research support from DMD Research Fund.
Jacob Evan Mr. Evan has received personal compensation for serving as an employee of Clene Nanomedicine. Mr. Evan has stock in Clene Nanomedicine .
Karen S. Ho, PhD Dr. Ho has received personal compensation for serving as an employee of Clene Nanomedicine. Dr. Ho has stock in Clene Nanomedicine.
William Huynh, MD Dr. Huynh has nothing to disclose.
Robert L. Glanzman, MD, FAAN Dr. Glanzman has received personal compensation for serving as an employee of Clene Nanomedicine Inc. Dr. Glanzman has stock in Clene Nanomedicine Inc .
Robert C. Griggs, MD, FAAN Dr. Griggs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Strongbridge Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idera Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biopharma. Dr. Griggs has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lippincott. The institution of Dr. Griggs has received research support from PTC Pharmaceuticals. The institution of Dr. Griggs has received research support from Sarepta Pharmaceuticals. The institution of Dr. Griggs has received research support from National Institutes of Health. The institution of Dr. Griggs has received research support from Santhere Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as a Study section member with National Institutes of Health. Dr. Griggs has a non-compensated relationship as a Board of Directors;Chair Research Advisory Committee with American Brain Foundation that is relevant to AAN interests or activities.
William Martens William Martens has nothing to disclose.
Wendy Marie King, PT Ms. King has nothing to disclose.
Chad J Swanson Chad J Swanson has received personal compensation for serving as an employee of Eisai Inc..
Janbernd Kirschner Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genethon. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Italfarmaco. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. The institution of Janbernd Kirschner has received research support from Roche. The institution of Janbernd Kirschner has received research support from Biogen. The institution of Janbernd Kirschner has received research support from Novartis.
Alrabi Tawil, MD, FAAN Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DYNE Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead Pharma. Dr. Tawil has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acceleron Pharma. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharma. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for miRecule. The institution of Dr. Tawil has received research support from Friends of FSH Research. The institution of Dr. Tawil has received research support from FSH Society. The institution of Dr. Tawil has received research support from NIH. The institution of Dr. Tawil has received research support from Fulcrum. Dr. Tawil has received intellectual property interests from a discovery or technology relating to health care. Dr. Tawil has received publishing royalties from a publication relating to health care.
Michael McDermott Michael McDermott has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm, Ltd.. Michael McDermott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Michael McDermott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis Pharmaceuticals, Inc.. Michael McDermott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex, Inc.. Michael McDermott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine Biosciences, Inc.. Michael McDermott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prilenia Therapeutics Development, Inc.. Michael McDermott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen BioPharma, Inc.. Michael McDermott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NS Pharma, Inc.. The institution of Michael McDermott has received research support from NIH. The institution of Michael McDermott has received research support from FDA. The institution of Michael McDermott has received research support from Cure SMA.
Tracey Willis, MD Prof. Willis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Willis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Prof. Willis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Prof. Willis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Prof. Willis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis.
Jennifer Wilkinson, PhD Dr. Wilkinson has nothing to disclose.
Mary Brown No disclosure on file
Kimberly A. Hart, MA No disclosure on file
Chris Speed, Other Mr. Speed has nothing to disclose.
Barbara Herr Barbara Herr has nothing to disclose.
Kate Bushby, MD Dr. Bushby has nothing to disclose.
Elaine McColl, PhD Prof. McColl has nothing to disclose.
Michelle Eagle, PhD,MSc,MCSP,SRP No disclosure on file
Shobha Dhadda Shobha Dhadda has received personal compensation for serving as an employee of Eisai Inc.
June Kaplow June Kaplow has received personal compensation for serving as an employee of Eisai Inc.. June Kaplow has a non-compensated relationship as a Participant member with ADNI that is relevant to AAN interests or activities.
Michio Kanekiyo Michio Kanekiyo has received personal compensation for serving as an employee of Eisai.
Randall Bateman, MD Dr. Bateman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for C2N Diagnostics . Dr. Bateman has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for C2N Diagnostics . Dr. Bateman has received stock or an ownership interest from C2N Diagnostics. The institution of Dr. Bateman has received research support from Alzheimer's SILQ Research Fund/ Barnes Jewish Hospital Foundation . The institution of Dr. Bateman has received research support from National Institutes of Health- R21AG067559. The institution of Dr. Bateman has received research support from Centene Corporation. The institution of Dr. Bateman has received research support from Rainwater Charitable Foundation . The institution of Dr. Bateman has received research support from Cure Alzheimer's Fund. The institution of Dr. Bateman has received research support from Cure Alzheimer's Fund. The institution of Dr. Bateman has received research support from Anonymous Foundation. The institution of Dr. Bateman has received research support from Cure Alzheimer's Fund. The institution of Dr. Bateman has received research support from BrightFocus Foundation. The institution of Dr. Bateman has received research support from Assn for Frontotemporal Degeneration FTD Biomarkers Initiative. The institution of Dr. Bateman has received research support from Rainwater Foundation. The institution of Dr. Bateman has received research support from NIH- R01NS095773. The institution of Dr. Bateman has received research support from AbbVie/Biogen/Eli Lilly. The institution of Dr. Bateman has received research support from NIH/NINDS/NIA- RF1AG061900 (R56AG061900 & R01NS065667). The institution of Dr. Bateman has received research support from Eisai. The institution of Dr. Bateman has received research support from Good Ventures Foundation. The institution of Dr. Bateman has received research support from National Institutes of Health- R01 AG070941. The institution of Dr. Bateman has received research support from National Institutes of Health-. The institution of Dr. Bateman has received research support from National Institutes of Health. The institution of Dr. Bateman has received research support from NIH- P50AG005681-36. The institution of Dr. Bateman has received research support from NIH/NIA- U19AG032438. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Pharma Consortium. The institution of Dr. Bateman has received research support from Eli Lilly . The institution of Dr. Bateman has received research support from NIH/NIA- NIH R01AG053267. The institution of Dr. Bateman has received research support from Administrative Supplement 01- NIH . The institution of Dr. Bateman has received research support from Administrative Supplement 02- NIH . The institution of Dr. Bateman has received research support from NIH- 1U01AG059798. The institution of Dr. Bateman has received research support from NIH- R01AG068319. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Roche. The institution of Dr. Bateman has received research support from NIH/NIA- R01AG046179. The institution of Dr. Bateman has received research support from GHR; Anonymous Foundation. The institution of Dr. Bateman has received research support from NIH/NIA- 1U01AG042791, 1U01AG042791. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from NIH/State Government- 5U19AG010483. Dr. Bateman has received intellectual property interests from a discovery or technology relating to health care.
Akihiko Koyama, PhD Dr. Koyama has received personal compensation for serving as an employee of Eisai Inc.. Dr. Koyama has stock in Eisai Co. Ltd..
Michael C. Irizarry, MD Dr. Irizarry has received personal compensation for serving as an employee of Eisai, Inc..
Christopher van Dyck, MD Christopher van Dyck, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Christopher van Dyck, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Christopher van Dyck, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Christopher van Dyck, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. An immediate family member of Christopher van Dyck, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supurnus. An immediate family member of Christopher van Dyck, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Polaris Management Partners. The institution of Christopher van Dyck, MD has received research support from Roche/Genentech. The institution of Christopher van Dyck, MD has received research support from Eli Lilly. The institution of Christopher van Dyck, MD has received research support from Biogen. The institution of Christopher van Dyck, MD has received research support from Biohaven. The institution of Christopher van Dyck, MD has received research support from Eisai. The institution of Christopher van Dyck, MD has received research support from UCB. The institution of Christopher van Dyck, MD has received research support from Cerevel. The institution of Christopher van Dyck, MD has received research support from Janssen.
Jeffrey Lee Cummings, MD, FAAN Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkahest. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Green Valley. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuaka. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for United Neuroscience. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Cummings has received research support from NIH. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
Robert Gordon Robert Gordon has received personal compensation for serving as an employee of Eisai Ltd.
David Li David Li has received personal compensation for serving as an employee of Eisai.
Lynn D. Kramer, MD, FAAN Dr. Kramer has received personal compensation for serving as an employee of Eisai Inc.
Afagh Garjani, MD The institution of Dr. Garjani has received research support from UK MS Society. Dr. Garjani has received personal compensation in the range of $0-$499 for serving as a Speaker with MS Academy. Dr. Garjani has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Biogen.
Graham Law, PhD Prof. Law has nothing to disclose.
Dhiren Bharkhada, Other Mr. Bharkhada has nothing to disclose.
Waqar Rashid Waqar Rashid has nothing to disclose.
Alasdair Coles, MD, PhD Dr. Coles has nothing to disclose.
Sameer Patel Mr. Patel has nothing to disclose.
Nikolaos Evangelou, PhD Dr. Evangelou has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis . Dr. Evangelou has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis . The institution of Dr. Evangelou has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Roche. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Evangelou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for UK crown prosecution service. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis .
Jody Goldstein No disclosure on file
Erin Furr-Stimming, MD, FAAN Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Michael J. Fox Foundation. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Furr-Stimming has received research support from Huntington's Disease Society of America. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care.
Daniel O. Claassen, MD, FAAN Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Neuroscience. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark . The institution of Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Neuroscience. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for HD Insights. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from Griffin Family Foundation. The institution of Dr. Claassen has received research support from Neurocrine. The institution of Dr. Claassen has received research support from Vaccinex. The institution of Dr. Claassen has received research support from AbbVie. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from Genentech/ Roche. The institution of Dr. Claassen has received research support from Prilenia. The institution of Dr. Claassen has received research support from Neurocrine/ HSG.
Hui Zhang, PhD Dr. Zhang has nothing to disclose.
Grace *use 112576 Liang No disclosure on file
Elise Paulin Kayson, RN Elise Paulin Kayson, RN has nothing to disclose.
Dietrich Haubenberger, MD, FAAN Dr. Haubenberger has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Haubenberger has stock in Neurocrine Biosciences. Dr. Haubenberger has a non-compensated relationship as a Member of the Board with American Society for Experimental Neurotherapeutics that is relevant to AAN interests or activities.
Erin Jackson Ms. Jackson has nothing to disclose.
Peter John Mitchell, MBBS Prof. Mitchell has received personal compensation in the range of $500-$4,999 for serving as a speaking at international meeting with styker. Prof. Mitchell has received personal compensation in the range of $0-$499 for serving as a speaker at international meeting with medtronic.
Jody Goldstein Ms. Goldstein has nothing to disclose.